Both T_H1 and T_H2 Cytokine mRNAs are Expressed in the NOD Mouse Pancreas in vivo

References

• Kikutani H., Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv. in Imunol. 1992; 51: 285–322
   PubMed Web of Science ®Google Scholar
• Tochino Y. The NOD mouse as a model of type I diabetes. Crit. Rev. Immunol. 1987; 8: 49–81
   PubMedGoogle Scholar
• Charlton B., Bacelj A., Slattery R. M., Mandel T. E. Cyclophosphamide‐induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes. 1989; 38: 441–447
   PubMed Web of Science ®Google Scholar
• Kay T. W., Campbell I. L., Harrison L. C. 1991. Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non‐obese diabetic (NOD) mouse. J. Autoimmunity. 1991; 4: 263–276
   PubMedGoogle Scholar
• Miyazaki A., Hanafusa T., Yamada K. Predominance of T lymphocytes in pancreatic islets and spleen of pre‐diabetic non‐obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol. 1985; 60: 622–630
   PubMed Web of Science ®Google Scholar
• Signore A., Pozzilli P., Gale A., Andreani D., Beverley P. C. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia. 1989; 32: 282–289
   PubMed Web of Science ®Google Scholar
• Christianson S. W., Shultz L. D., Leiter E. H. Adoptive transfer of diabetes into immunodeficient NOD‐scid/scid mice. Relative contributions of CD4 + and CD8 + T‐cells from diabetic versus prediabetic NOD. NON‐Thy‐la donors. Diabetes. 1993; 42: 44–55
   PubMed Web of Science ®Google Scholar
• Yasunami R., Bach J. F. Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 1988; 18: 481–484
   PubMed Web of Science ®Google Scholar
• Reich E. P., Scaringe F., Yagi J., Sherwin R. S., Janeway C. J. Prevention of diabetes in NOD mice by injection of autoreactive T‐lymphocytes. Diabetes. 1989; 38: 1647–1651
   PubMedGoogle Scholar
• Chosich N., Harrison L. C. Suppression of diabetes mellitus in the non‐obese diabetic (NOD) mouse by an autoreactive (anti‐I‐Ag7) islet‐derived CD4+ T‐cell line. Diabetologia. 1993; 36: 716–721
   PubMedGoogle Scholar
• Hutchings P. R., Cooke A. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmunity. 1990; 3: 175–185
   PubMed Web of Science ®Google Scholar
• Boitard C., Yasunami R., Dardenne M., Bach J. F. T cell‐mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 1989; 169: 1669–1680
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Schumacher J. H., Street N. F. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Rev. 1991; 123: 209–229
   PubMed Web of Science ®Google Scholar
• Moore K. W., O'Garra A., de Waal M. R., Vieira P., Mosmann T. R. Interleukin‐10. Annu. Rev. Immunol. 1993; 11: 165–90
   PubMed Web of Science ®Google Scholar
• Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of TH1 CD4+ T cells through IL‐12 produced by Listeria‐induced macrophages. Science 1993; 260: 547–549
   PubMed Web of Science ®Google Scholar
• Sher A., Coffman R. L. Regulation of immunity to parasites by T cells and T cell‐derived cytokines. Ann. Rev. Immunol. 1992; 10: 385–409
   PubMed Web of Science ®Google Scholar
• Reed S. G., Scott P. T‐cell and cytokine responses in leishmaniasis. Current opinion in immunol. 1993; 5: 524–531
   PubMed Web of Science ®Google Scholar
• Morris L., Troutt A. B., Handman E., Kelso A. Changes in the precursor frequencies of IL‐4 and IFN‐gamma secreting CD4 + cells correlate with resolution of lesions in murine cutaneous leishmaniasis. J. Immunol. 1992; 149: 2715–2721
   PubMedGoogle Scholar
• Honeyman M. C., Harrison L. C. The immunologic insult in type 1 diabetes. Semin. Immunopathol. 1993; 5: 253–274
   Google Scholar
• Bach J. 1994. Insulin‐dependent diabetes mellitus as an autoimmune disease. Endocrine Rev. 1994; 15: 516
   PubMed Web of Science ®Google Scholar
• Shehadeh N. N., LaRosa F., Lafferty K. J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmunity. 1993; 6: 291–300
   PubMed Web of Science ®Google Scholar
• Baxter A. G., Koulmanda M., Mandel T. E. High and low diabetes incidence non obese diabetic (NOD) mice: origins and characterisation. Autoimmunity. 1993; 9: 61–67
   Google Scholar
• Faulkner‐Jones B. E., Cram D. S., Kun J., Harrison L. C. Localisation and quantitation of expression of two gutamate decarboxylase genes in pancreatic β‐cells and other peripheral tissues of mouse and rat. Endocrinology. 1993; 133: 2962–2972
   PubMed Web of Science ®Google Scholar
• Foley K. P., Leonard M. W., Engel J. D. Quantitation of RNA using the polymerase chain reaction. TIG. 1993; 9: 380–385
   PubMed Web of Science ®Google Scholar
• Faulkner‐Jones B. E. Of sweet mice, stiff men and cytokines. Analysis of the expression patterns of glutamate decarboxylase and T‐lymphocyte cytokines with emphasis on their relevance to insulin dependent diabetes mellitus. PhD. thesis, University of Melbourne, Australia 1994
   Google Scholar
• Dallman M. J., Montgomery R. A., Larsen C. P., Wanders A., Wells A. F. Cytokine gene expression: analysis using northern blotting, polymerase chain reaction and in situ hybridization. Immunol. Rev. 1991; 119: 163–79
   PubMed Web of Science ®Google Scholar
• Kennedy M. K., Torrance D. S., Picha K. S., Mohler K. M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomylitis reveals that IL‐10 mRNA expression correlates with recovery. J. Immunol. 1992; 149: 2496–505
   PubMed Web of Science ®Google Scholar
• Anderson J. T., Cornelius J. G., Jarpe A. J., Winter W. E., Peck A. B. Insulin‐dependent diabetes in the NOD mouse model II. β‐cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. Autoimmunity. 1993; 15: 113–22
   PubMed Web of Science ®Google Scholar
• Rothe H., Faust A., Schade U., Kleemann R., Hibino T., Martin S., Kolb H. Cyclophosphamide treatment of female non‐obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon‐gamma, but not of interleukin‐4. Diabetologia. 1994; 37: 1154–1158
   PubMed Web of Science ®Google Scholar